Citations

Mayo Clinic

Showing 10 of 108599 citations.

The Almost-Normal Liver Biopsy
Czeczok, Thomas , Arnam, John S. Van , Wood, Laura D. , Mounajjed, Taofic, Czeczok, Thomas W, Torbenson, Michael

American Journal of Surgical Pathology | June 14, 2017 | Volume: 41 | Issue: 9 | Pages: 1247-1253

10.1097/pas.0000000000000881 | PMID 28614198 Get It

Liver biopsies obtained for abnormal liver enzymes or unexplained ascites occasionally appear histologically almost normal. The differential diagnosis for these cases is challenging because literature addressing this topic is lacking. We aimed to establish a differential diagnosis and determine clinical associations and outcomes for almost-normal liver biopsies. Ninety-seven histologically almost-normal liver biopsies were collected from 2 institutions. All cases lacked significant inflammation, fatty change, biliary tract disease, vascular disease, nodular regenerative hyperplasia, iron overload, inherited metabolic or storage disorder, viral hepatitis, or fibrosis. Biopsies for follow-up of known liver diseases were excluded. Transplant biopsies, lesion-directed biopsies, biopsies obtained during bariatric surgery, liver donor biopsies, and biopsies to evaluate methotrexate toxicity were excluded. Clinical (including follow-up) and laboratory data were collected. The frequency of almost-normal liver biopsies was 0.6% and 3.7% at the 2 institutions. The most common biopsy indications were elevated liver biochemistries or clinical findings that suggested portal hypertension. In 70 patients (72%), an associated clinical abnormality was identified; the most common were autoimmune systemic inflammatory conditions (18%), vascular/ischemic events (13%), metabolic syndrome (11%), drug effects (8%), and inflammatory conditions of the gastrointestinal tract (7%). The median follow-up period was 4.3 years (range=0 to 10 y); detailed clinical follow-up was available for 66 patients (68%). Liver biochemistries normalized in 32 patients (48.5%) and remained elevated in 34 (51.5%). Seven patients (7.2%) eventually developed chronic liver disease (autoimmune hepatitis [n=3], primary biliary cirrhosis [n=3], cryptogenic cirrhosis [n=1]). This multicenter study determines the differential diagnosis for almost-normal liver biopsies; this will guide pathologists in subsequent workup efforts in these challenging cases.
Analysis of a Physician-led, Team-based Care Model for the Treatment of Glaucoma
Winkler, Nelson S., Damento, Gena M., Khanna, Sunil S., Hodge, David O. , Khanna, Cheryl L.

Journal of Glaucoma | June 14, 2017 | Volume: 26 | Issue: 8 | Pages: 702-707

10.1097/ijg.0000000000000689 | PMID 28617721 Get It

Purpose: To determine the effect of a protocol for a new physician-led, team-based glaucoma care model implemented in 2008 at Mayo Clinic’s campus in Rochester, Minnesota (MCR), to increase conformance with the American Academy of Ophthalmology (AAO) Preferred Practice Pattern guidelines for treatment of primary open-angle glaucoma. Methods: Records of 591 patients with newly diagnosed glaucoma were assessed retrospectively for the completion of 9 AAO Preferred Practice Pattern recommended metrics including measured corneal thickness, intraocular pressure (IOP), cup to disk ratio, visual acuity, recorded IOP target, gonioscopy, fundus photos, ocular coherence tomography, and visual field in the 3 years before and 3 years after protocol implementation. Treatment by the glaucoma care team at MCR was compared with treatment at a community-based general ophthalmology practice and with a group of comprehensive ophthalmologists at MCR without team care, which served as controls. Results: Adherence to AAO recommendations increased for the documentation of target IOP (+24%, 42.6% to 66.7%; P=0.007), gonioscopy (+27%, 66.7% to 93.3%; P≤0.001), fundus photos (+29%, 44.4% to 73.3%; P≤0.001), and ocular coherence tomography (+20%, 48.1% to 68.0%; P=0.02) after protocol initiation. No change in pattern of testing occurred in the control groups without team care during the same time period. Type and severity of glaucoma were similar between MCR and community practice. Conclusions: An increase in compliance with AAO guidelines was found after implementation of our protocol for a physician-led, team-based care model to standardize glaucoma care among providers.
Importance of Artificial Pancreas Standard Nomenclature
Basu, Ananda

Diabetes Technology & Therapeutics | June 14, 2017 | Volume: 19 | Issue: 6 | Pages: 323-323

10.1089/dia.2017.0169 | PMID 28613949 Get It

Early‐life decline in neurogenesis markers and age‐related changes of TrkB splice variant expression in the human subependymal zone
Weissleder, Christin , Kondo, Mari , Yang, Chunhui , Fung, Samantha J., Rothmond, Debora A. , Wong, Matthew Wai Kin , Halliday, Glenda M. , Herman, Mary M., Weickert, Cynthia Shannon , Kleinman, Joel E , Webster, Maree J. , Halliday, Glenda , Weissleder, Christin

European Journal of Neuroscience | June 14, 2017 | Volume: 46 | Issue: 2 | Pages: 1768-1778

10.1111/ejn.13623 | PMID 28612959 Get It

AbstractNeurogenesis in the subependymal zone (SEZ) declines across the human lifespan, and reduced local neurotrophic support is speculated to be a contributing factor. While tyrosine receptor kinase B (TrkB) signalling is critical for neuronal differentiation, maturation and survival, little is known about subependymal TrkB expression changes during postnatal human life. In this study, we used quantitative PCR and in situ hybridisation to determine expression of the cell proliferation marker Ki67, the immature neuron marker doublecortin (DCX) and both full‐length (TrkB‐TK+) and truncated TrkB receptors (TrkB‐TK‐) in the human SEZ from infancy to middle age (n = 26–35, 41 days to 43 years). We further measured TrkB‐TK+ and TrkB‐TK‐ mRNAs in the SEZ from young adulthood into ageing (n = 50, 21–103 years), and related their transcript levels to neurogenic and glial cell markers. Ki67, DCX and both TrkB splice variant mRNAs significantly decreased in the SEZ from infancy to middle age. In contrast, TrkB‐TK‐ mRNA increased in the SEZ from young adulthood into ageing, whereas TrkB‐TK+ mRNA remained stable. TrkB‐TK‐ mRNA positively correlated with expression of neural precursor (glial fibrillary acidic protein delta and achaete‐scute homolog 1) and glial cell markers (vimentin and pan glial fibrillary acidic protein). TrkB‐TK+ mRNA positively correlated with expression of neuronal cell markers (DCX and tubulin beta 3 class III). Our results indicate that cells residing in the human SEZ maintain their responsiveness to neurotrophins; however, this capability may change across postnatal life. We suggest that TrkB splice variants may differentially influence neuronal and glial differentiation in the human SEZ.
Genomic landscape and evolution of metastatic chromophobe renal cell carcinoma
Casuscelli, Jozefina , Gundem, Gunes , Wang, Lu , Zabor, Emily C. , Drill, Esther , Wang, Patricia I., Nanjangud, Gouri J. , Redzematovic, Almedina, Nargund, Amrita M. , Manley, Brandon J. , Arcila, Maria E. , Donin, Nicholas M. , Cheville, John C. , Thompson, R. Houston, Pantuck, Allan J., Russo, Paul , Cheng, Emily H. , Lee, William , Tickoo, Satish K. , Ostrovnaya, Irina , Creighton, Chad J. , Papaemmanuil, Elli , Seshan, Venkatraman , Hsieh, James J. , Weinhold, Nils , Hakimi, A Ari , Manley, Brandon J

JCI Insight | June 14, 2017 | Volume: 2 | Issue: 12 | Pages: No page available

10.1172/jci.insight.92688 | PMID 28614790 Get It

Chromophobe renal cell carcinoma (chRCC) typically shows ~7 chromosome losses (1, 2, 6, 10, 13, 17, and 21) and ~31 exonic somatic mutations, yet carries ~5%–10% metastatic incidence. Since extensive chromosomal losses can generate proteotoxic stress and compromise cellular proliferation, it is intriguing how chRCC, a tumor with extensive chromosome losses and a low number of somatic mutations, can develop lethal metastases. Genomic features distinguishing metastatic from nonmetastatic chRCC are unknown. An integrated approach, including whole-genome sequencing (WGS), targeted ultradeep cancer gene sequencing, and chromosome analyses (FACETS, OncoScan, and FISH), was performed on 79 chRCC patients including 38 metastatic (M-chRCC) cases. We demonstrate that TP53 mutations (58%), PTEN mutations (24%), and imbalanced chromosome duplication (ICD, duplication of ≥ 3 chromosomes) (25%) were enriched in M-chRCC. Reconstruction of the subclonal composition of paired primary-metastatic chRCC tumors supports the role of TP53 , PTEN , and ICD in metastatic evolution. Finally, the presence of these 3 genomic features in primary tumors of both The Cancer Genome Atlas kidney chromophobe (KICH) ( n = 64) and M-chRCC ( n = 35) cohorts was associated with worse survival. In summary, our study provides genomic insights into the metastatic progression of chRCC and identifies TP53 mutations, PTEN mutations, and ICD as high-risk features.
Midostaurin for the treatment of acute myeloid leukemia
Patnaik, Mrinal M.

Future Oncology | June 14, 2017 | Volume: 13 | Issue: 21 | Pages: 1853-1871

10.2217/fon-2017-0160 | PMID 28610444 Get It

Personality Disorders in Primary Care: Impact on Depression Outcomes Within Collaborative Care
Angstman, Kurt B. , Seshadri, Ashok , Marcelin, Alberto, González, César A. , Garrison, Gregory M. , Allen, Jay-Sheree , Gonzalez, Cesar

Journal of Primary Care & Community Health | June 14, 2017 | Volume: 8 | Issue: 4 | Pages: 233-238

10.1177/2150131917714929 | PMID 28613090 Get It

Background:Individuals with personality disorders (PDs) are high utilizers of primary care and mental health services; however, they struggle to utilize the care effectively and studies have shown a strong association between having a PD and higher impairment in social role functioning. This is especially important because PDs are highly comorbid with a wide range of other mental health disorders. The collaborative care model (CCM) for depression was developed with an emphasis on patient engagement and aimed to reduce health care utilization, while improving treatment outcomes in primary care. We hypothesized that the diagnosis of a personality disorder in primary care patients will negatively affect 6-month depression outcomes after enrollment into a CCM. Methods: This retrospective chart review study was conducted on patients enrolled into CCM over a period of 7 years with collection of 6-month follow-up data. A total of 2826 patients were enrolled into CCM with a clinical diagnosis of depression and a baseline Patient Health Questionnaire–9 (PHQ-9) ≥10 were included in the study cohort. Using the depression database, baseline and 6-month follow-up data were obtained. Adjusted odds ratios (AORs) were determined for both remission and persistent depressive symptoms using logistic regression modeling for the 6-month PHQ-9 outcome; while retaining all the study variables. Results: Of the 2826 CCM patients with depression in our study, 216 (7.6%) were found to have a PD. Patients with PD were younger (37.7 vs 42.5 years, P < .001) and more likely to be unmarried (36.1% vs 55.6%, P < .001) than patients without a PD. While age, marital status, clinical diagnosis, and Mood Disorders Questionnaire (MDQ) score were significant predictors of remission; anxiety symptoms, gender, and race were not. The presence of a PD diagnosis was associated with a 60% lower likelihood of remission at 6 months (AOR = 0.39; 95% CI 0.28-0.54). Conversely, patients without a PD were 2.5 times as likely to experience remission at 6-month remission compared to patients with PD (AOR =2.57; 95% CI 1.85-3.56). Conclusion: Patients with a personality disorder were more likely to have a recurrent depressive disorder diagnosis, an abnormal MDQ score, increased anxiety symptoms, and higher baseline PHQ-9 score. Patients with PD had worse CCM outcomes at 6 months with only 25.0% able to achieve remission versus 54.3% ( P < .001) without a PD. The presence of a PD with depression was associated with poor outcomes (reduced remission rates and increased persistent depressive symptoms rates) in comparison to patients without a diagnosis of PD, while treated within CCM.
Response to Letter by Friedman on “Incidence and time trends of drug‐induced parkinsonism: A 30‐year population‐based study”
Rocca, Walter A. , Savica, Rodolfo , Grossardt, Brandon R.

Movement Disorders | June 14, 2017 | Volume: 32 | Issue: 7 | Pages: 1111-1112

10.1002/mds.27051 | PMID 28612941 Get It

Faculty Opinions recommendation of Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study.
Huebert, Robert C.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 14, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727687873.793532957 Get It